Prevention of deep venous thrombosis in orthopedic surgery: effects of defibrotide

R Zanasi1, G Fioretta, G Ciocia

  • 1Orthopedics Department, Fatebenefratelli Hospital, Milan, Italy.

Clinical Therapeutics
|January 1, 1988
PubMed

Insights

Defibrotide showed a promising trend in preventing symptomatic deep venous thrombosis (DVT) and pulmonary embolism after orthopedic surgery compared to calcium heparin and aspirin (ASA). This suggests defibrotide is a viable alternative for DVT prophylaxis.

Area of Science:

  • Orthopedic Surgery
  • Vascular Medicine
  • Pharmacology

Background:

  • Deep venous thrombosis (DVT) is a significant risk following orthopedic surgery.
  • Current prophylactic measures include calcium heparin and acetylsalicylic acid (ASA).
  • Novel therapeutic strategies are being explored to improve DVT prevention.

Purpose of the Study:

  • To compare the efficacy of defibrotide against calcium heparin and ASA in preventing DVT post-orthopedic surgery.
  • To evaluate the incidence of symptomatic DVT and pulmonary embolism in patients receiving different prophylactic treatments.

Main Methods:

  • A randomized controlled trial involving 63 patients undergoing hip or other orthopedic surgery.
  • Patients were assigned to receive defibrotide, calcium heparin, or ASA for DVT prophylaxis.
  • Fibrinogen uptake tests were used for daily monitoring, alongside clinical assessment for DVT and pulmonary embolism.

Main Results:

  • No significant difference in fibrinogen uptake was observed across the three treatment groups.
  • Defibrotide demonstrated a trend towards lower rates of symptomatic DVT (1/19) compared to calcium heparin (2/25) and ASA (4/19).
  • Defibrotide showed no cases of pulmonary embolism, while calcium heparin had one and ASA had two.

Conclusions:

  • Defibrotide therapy presents a valid alternative for deep venous thrombosis prophylaxis in orthopedic surgery patients.
  • The findings suggest a potential benefit of defibrotide in reducing symptomatic DVT and pulmonary embolism.
  • Further research may be warranted to confirm the efficacy of defibrotide in this patient population.

Related Concept Videos

Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...